RSS   Newsletter   Contact   Advertise with us

Targovax appoints Damian Marron as chairman

Christian Fernsby | Oslo, Norway | April 3, 2020
Damian MarronTargovax, a clinical stage biotechnology company, announces that its nomination committee has nominated Damian Marron for election as chairman of the board.
Mr. Marron is an experienced non-executive director, corporate advisor and life science executive with a successful track record of value creation through public and venture capital financing, portfolio planning, M&A, licensing agreements as well as R&D collaborations, both as an executive and in advisory roles.

Mr. Marron has notably specialized in immuno-oncology, cell therapy and orphan diseases.

Mr. Marron is currently Non-Executive Director at Bone Therapeutics a clinical stage, regenerative medicine company listed on Euronext and Resolys Bio, a private, late pre-clinical US startup.

He is also Head of Biopharma with Treehill Partners, a global pure-play healthcare advisory firm.

Mr. Marron has formerly been Chair of the Board of PepGen Ltd and the CEO at Agalimmune Ltd, TxCell SA, Cytheris SA, and Trophos SA.


 LATEST MOVES FROM Norway 


MORE INSIDE POST